Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001641172-25-014724
Filing Date
2025-06-11
Accepted
2025-06-11 16:35:34
Documents
15
Effectiveness Date
2025-06-11

Document Format Files

Seq Description Document Type Size
1 S-8 forms-8.htm S-8 94948
2 EX-5.1 ex5-1.htm EX-5.1 10745
3 EX-23.2 ex23-2.htm EX-23.2 3956
4 EX-FILING FEES ex107.htm   iXBRL EX-FILING FEES 35416
5 GRAPHIC ex5-1_001.jpg GRAPHIC 8239
  Complete submission text file 0001641172-25-014724.txt   280105

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT ex107_htm.xml XML 5928
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (617) 798-6700
Ernexa Therapeutics Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-287955 | Film No.: 251040534
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)